These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12376313)

  • 1. Expression of FAS within hypothalamic neurons: a model for decreased food intake after C75 treatment.
    Kim EK; Miller I; Landree LE; Borisy-Rudin FF; Brown P; Tihan T; Townsend CA; Witters LA; Moran TH; Kuhajda FP; Ronnett GV
    Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E867-79. PubMed ID: 12376313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a fatty acid synthase inhibitor on food intake and expression of hypothalamic neuropeptides.
    Shimokawa T; Kumar MV; Lane MD
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):66-71. PubMed ID: 11756683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects.
    Hu Z; Cha SH; van Haasteren G; Wang J; Lane MD
    Proc Natl Acad Sci U S A; 2005 Mar; 102(11):3972-7. PubMed ID: 15728730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the anorectic fatty acid synthase inhibitor C75 on neuronal activity in the hypothalamus and brainstem.
    Gao S; Lane MD
    Proc Natl Acad Sci U S A; 2003 May; 100(10):5628-33. PubMed ID: 12724522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin is not a prerequisite for rapid regulation of neuropeptide Y gene transcription in the arcuate nucleus in food-restricted rats.
    Goto M; Arima H; Hiroi M; Shimizu H; Watanabe M; Hayashi M; Banno R; Sato I; Ozaki N; Nagasaki H; Oiso Y
    Neurosci Lett; 2007 Jun; 420(1):61-5. PubMed ID: 17462823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic malonyl-CoA as a mediator of feeding behavior.
    Hu Z; Cha SH; Chohnan S; Lane MD
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12624-9. PubMed ID: 14532332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator.
    Takahashi KA; Smart JL; Liu H; Cone RD
    Endocrinology; 2004 Jan; 145(1):184-93. PubMed ID: 14512433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
    Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y content in the hypothalamic paraventricular nucleus responds to fasting and refeeding in broiler chickens.
    Zhou W; Murakami M; Hasegawa S; Yoshizawa F; Sugahara K
    Comp Biochem Physiol A Mol Integr Physiol; 2005 Jun; 141(2):146-52. PubMed ID: 15982913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response of arcuate proopiomelanocortin- and neuropeptide Y-containing neurons to the lesion produced by gold thioglucose administration.
    Homma A; Li HP; Hayashi K; Kawano Y; Kawano H
    J Comp Neurol; 2006 Nov; 499(1):120-31. PubMed ID: 16958086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of centrally administered C75, a fatty acid synthase inhibitor, on gastric emptying and gastrointestinal transit in mice.
    Li LF; Lu YY; Xiong W; Liu JY; Chen Q
    Eur J Pharmacol; 2008 Oct; 595(1-3):90-4. PubMed ID: 18706411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the inactivation of rat fatty acid synthase by C75: inhibition of partial reactions and protection by substrates.
    Rendina AR; Cheng D
    Biochem J; 2005 Jun; 388(Pt 3):895-903. PubMed ID: 15715522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of food intake by inhibitors of fatty acid synthase.
    Bouchard C
    N Engl J Med; 2000 Dec; 343(25):1888-9. PubMed ID: 11117983
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatty acid metabolism as a target for obesity treatment.
    Ronnett GV; Kim EK; Landree LE; Tu Y
    Physiol Behav; 2005 May; 85(1):25-35. PubMed ID: 15878185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
    Menendez JA; Lupu R
    Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus.
    Fetissov SO; Byrne LC; Hassani H; Ernfors P; Hökfelt T
    J Comp Neurol; 2004 Mar; 470(3):256-65. PubMed ID: 14755515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase.
    Kim EK; Miller I; Aja S; Landree LE; Pinn M; McFadden J; Kuhajda FP; Moran TH; Ronnett GV
    J Biol Chem; 2004 May; 279(19):19970-6. PubMed ID: 15028725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice.
    Alli PM; Pinn ML; Jaffee EM; McFadden JM; Kuhajda FP
    Oncogene; 2005 Jan; 24(1):39-46. PubMed ID: 15489885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
    Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
    Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.